8d
Zacks.com on MSNMRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab CapvaxiveCommittee for Medicinal Products for Human Use (CHMP) has recommended the approval of its 21-valent pneumococcal conjugate ...
7d
Zacks.com on MSNCHMP Gives Nod to Expanded Use of J&J's Rybrevant & AZN's ImfinziJohnson & Johnson JNJ announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ...
The European Medicines Agency’s positive opinion for ivermectin-albendazole for treating soil-transmitted helminth infections ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...
Bristol Myers on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Breyanzi for the treatment of adults with relapsed or refractory ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
Janssen-Cilag International NV, a Johnson & Johnson company, received European Medicines Agency's Committee for Medicinal Products ...
7d
GlobalData on MSNAstraZeneca lung cancer therapy Imfinzi recommended for EU approvalThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended AstraZeneca's Imfinzi ...
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive ...
Vaccination with CAPVAXIVE may not protect all vaccine recipients.
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results